Why You Should Like MeVis Medical Solutions AG’s (ETR:M3V) ROCEHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Why You Should Like MeVis Medical Solutions AG’s (ETR:M3V) ROCESimply Wall StSimply Wall St.January 8, 2020ReblogShareTweetShareView photosToday we are going to look at MeVis Medical Solutions AG (ETR:M3V) to see whether it might be an attractive investment prospect. Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business.First of all, we'll work out how to calculate ROCE. Then we'll compare its ROCE to similar companies. Then we'll determine how its current liabilities are affecting its ROCE.Understanding Return On Capital Employed (ROCE)ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. All else being equal, a better business will have a higher ROCE. Ultimately, it is a useful but imperfect metric. Author Edwin Whiting says to be careful when comparing the ROCE of different businesses, since 'No two businesses are exactly alike.How Do You Calculate Return On Capital Employed?The formula for calculating the return on capital employed is:Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)Or for MeVis Medical Solutions:0.21 = €8.2m ÷ (€42m - €3.6m) (Based on the trailing twelve months to June 2019.)So, MeVis Medical Solutions has an ROCE of 21%.
Check out our latest analysis for MeVis Medical Solutions Does MeVis Medical Solutions Have A Good ROCE?ROCE can be useful when making comparisons, such as between similar companies. In our analysis, MeVis Medical Solutions's ROCE is meaningfully higher than the 17% average in the Healthcare Services industry. We consider this a positive sign, because it suggests it uses capital more efficiently than similar companies. Regardless of the industry comparison, in absolute terms, MeVis Medical Solutions's ROCE currently appears to be excellent.Our data shows that MeVis Medical Solutions currently has an ROCE of 21%, compared to its ROCE of 15% 3 years ago. This makes us think the business might be improving. You can click on the image below to see (in greater detail) how MeVis Medical Solutions's past growth compares to other companies.XTRA:M3V Past Revenue and Net Income, January 8th 2020MoreWhen considering ROCE, bear in mind that it reflects the past and does not necessarily predict the future. Companies in cyclical industries can be difficult to understand using ROCE, as returns typically look high during boom times, and low during busts. ROCE is only a point-in-time measure. How cyclical is MeVis Medical Solutions? You can see for yourself by looking at this free graph of past earnings, revenue and cash flow.Do MeVis Medical Solutions's Current Liabilities Skew Its ROCE?Liabilities, such as supplier bills and bank overdrafts, are referred to as current liabilities if they need to be paid within 12 months. Due to the way the ROCE equation works, having large bills due in the near term can make it look as though a company has less capital employed, and thus a higher ROCE than usual. To counter this, investors can check if a company has high current liabilities relative to total assets.MeVis Medical Solutions has total liabilities of €3.6m and total assets of €42m. As a result, its current liabilities are equal to approximately 8.6% of its total assets. MeVis Medical Solutions has low current liabilities, which have a negligible impact on its relatively good ROCE.Story continuesWhat We Can Learn From MeVis Medical Solutions's ROCEThis should mark the company as worthy of further investigation. MeVis Medical Solutions shapes up well under this analysis,
but it is far from the only business delivering excellent numbers . You might also want to check this free collection of companies delivering excellent earnings growth.For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextA Close Look At King's Flair International (Holdings) Limited’s (HKG:6822) 20% ROCESimply Wall St.Here’s why Suga International Holdings Limited’s (HKG:912) Returns On Capital Matters So MuchSimply Wall St.What Does TL Natural Gas Holdings Limited’s (HKG:8536) 14% ROCE Say About The Business?Simply Wall St.Is Seven Group Holdings Limited's (ASX:SVW) Capital Allocation Ability Worth Your Time?Simply Wall St.Is There More To Nissin Foods Company Limited (HKG:1475) Than Its 8.3% Returns On Capital?Simply Wall St.Biocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoWhy BE Group AB (publ) (STO:BEGR) Is A Dividend RockstarSimply Wall St.'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video